Diagnostic and prognostic value of [18F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma

Journal of Clinical Oncology

Volumn 20, Issue 20, 2002, Pages 4199-4208

  Wong, R J ^a   Lin, D T ^a   Schoder H ^a   Patel, S G ^a   Gonen, M ^a   Wolden, S ^a   Pfister, D G ^a   Shah, J P ^a   Larson, S M ^a   Kraus, Dennis H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AREA UNDER THE CURVE; ARTICLE; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037108697     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.02.590     Document Type: Article

References (17)

1. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 52:23-47, 2002
2. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med 328:184-194, 1993
3. Warburg O: Metabolism of Tumors. New York, NY, Richard R. Smith, 1931
4. Weber G: Enzymology of cancer cells: Part 2. N Engl J Med 296:541-551, 1977
5. Phelps ME: Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci U S A 97:9226-9233, 2000
6. Lonneaux M, Lawson G, Ide C, et al: Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 110:1493-1497, 2000
7. Stokkel MP, Terhaard CH, Hordijk GJ, et al: The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 26:767-773, 1999
8. Lapela M, Eigtved A, Jyrkkio S, et al: Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 36:858-867, 2000
9. 18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 109:970-975, 1999
10. Greven KM, Williams DW, McGuirt WF, et al: Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23:942-946, 2001
11. Lowe VJ, Boyd JH, Dunphy FR, et al: Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18:651-658, 2000
12. Terhaard CH, Bongers V, van Rijk PP, et al F-18-Fluorodeoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 23:933-941, 2001
13. Bamber D: The area above the ordinal dominance graph and the area below the receiver operating characteristic graph. J Math Psychol 12:387-415, 1975
14. Kalbfleisch JD, Prenctice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
15. Goodwin WJ: Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means? Laryngoscope 110:1-18, 2000 (suppl 93)
16. Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL: Reevaluation of the standardized uptake value for FDG: Variations with body weight and methods for correction. Radiology 213:521-525, 1999
17. Keyes JW Jr: SUV: Standard uptake or silly useless value? J Nucl Med 36:1836-1839, 1995